These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 27869279

  • 1. Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization.
    Yellol J, Pérez SA, Yellol G, Zajac J, Donaire A, Vigueras G, Novohradsky V, Janiak C, Brabec V, Ruiz J.
    Chem Commun (Camb); 2016 Dec 01; 52(98):14165-14168. PubMed ID: 27869279
    [Abstract] [Full Text] [Related]

  • 2. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
    Lee PK, Law WH, Liu HW, Lo KK.
    Inorg Chem; 2011 Sep 05; 50(17):8570-9. PubMed ID: 21834537
    [Abstract] [Full Text] [Related]

  • 3. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G, Mijatović S, Ranđelović I, Bulatović M, Miljković D, Maksimović-Ivanić D, Korb M, Lang H, Steinborn D, Kaluđerović GN.
    Eur J Med Chem; 2013 Nov 05; 69():216-22. PubMed ID: 24042044
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
    Song XD, Kong X, He SF, Chen JX, Sun J, Chen BB, Zhao JW, Mao ZW.
    Eur J Med Chem; 2017 Sep 29; 138():246-254. PubMed ID: 28668477
    [Abstract] [Full Text] [Related]

  • 6. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C, Acuña MI, Busto N, Echevarría I, Martínez-Alonso M, Espino G, García B, Domínguez F.
    Eur J Med Chem; 2018 Sep 05; 157():279-293. PubMed ID: 30099251
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
    Lucas SJ, Lord RM, Wilson RL, Phillips RM, Sridharan V, McGowan PC.
    Dalton Trans; 2012 Dec 07; 41(45):13800-2. PubMed ID: 23015068
    [Abstract] [Full Text] [Related]

  • 8. "Half-sandwich" Schiff-base Ir(III) complexes as anticancer agents.
    Mou ZD, Deng N, Zhang F, Zhang J, Cen J, Zhang X.
    Eur J Med Chem; 2017 Sep 29; 138():72-82. PubMed ID: 28646657
    [Abstract] [Full Text] [Related]

  • 9. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J, Pérez SA, Buceta A, Yellol G, Donaire A, Szumlas P, Bednarski PJ, Makhloufi G, Janiak C, Espinosa A, Ruiz J.
    J Med Chem; 2015 Sep 24; 58(18):7310-27. PubMed ID: 26313136
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes.
    Liu Z, Salassa L, Habtemariam A, Pizarro AM, Clarkson GJ, Sadler PJ.
    Inorg Chem; 2011 Jun 20; 50(12):5777-83. PubMed ID: 21618978
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR, Nongbri SL, Premkumar JR, Verma AK, Bhattacharjee K, Joshi SR, Forbes S, Mozharivskyj Y, Thounaojam R, Aguan K, Kollipara MR.
    J Biol Inorg Chem; 2015 Jun 20; 20(4):619-38. PubMed ID: 25712889
    [Abstract] [Full Text] [Related]

  • 13. Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes.
    Boff B, Gaiddon C, Pfeffer M.
    Inorg Chem; 2013 Mar 04; 52(5):2705-15. PubMed ID: 23427955
    [Abstract] [Full Text] [Related]

  • 14. Lysosome-targeted chemotherapeutics: Anticancer mechanism of N-heterocyclic carbene iridium(III) complex.
    Zhang J, Liu J, Liu X, Liu B, Song S, He X, Che C, Si M, Yang G, Liu Z.
    J Inorg Biochem; 2020 Jun 04; 207():111063. PubMed ID: 32222581
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity.
    Lu L, Liu LJ, Chao WC, Zhong HJ, Wang M, Chen XP, Lu JJ, Li RN, Ma DL, Leung CH.
    Sci Rep; 2015 Sep 29; 5():14544. PubMed ID: 26416333
    [Abstract] [Full Text] [Related]

  • 18. Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies.
    Li J, Guo L, Tian Z, Zhang S, Xu Z, Han Y, Li R, Li Y, Liu Z.
    Inorg Chem; 2018 Nov 05; 57(21):13552-13563. PubMed ID: 30289251
    [Abstract] [Full Text] [Related]

  • 19. Thiourea and Guanidine Compounds and Their Iridium Complexes in Drug-Resistant Cancer Cell Lines: Structure-Activity Relationships and Direct Luminescent Imaging.
    Thomas SJ, Balónová B, Cinatl J, Wass MN, Serpell CJ, Blight BA, Michaelis M.
    ChemMedChem; 2020 Feb 17; 15(4):349-353. PubMed ID: 31828886
    [Abstract] [Full Text] [Related]

  • 20. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
    Song XD, Chen BB, He SF, Pan NL, Liao JX, Chen JX, Wang GH, Sun J.
    Eur J Med Chem; 2019 Oct 01; 179():26-37. PubMed ID: 31233920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.